DK1885380T3 - Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme - Google Patents

Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme

Info

Publication number
DK1885380T3
DK1885380T3 DK06732912.8T DK06732912T DK1885380T3 DK 1885380 T3 DK1885380 T3 DK 1885380T3 DK 06732912 T DK06732912 T DK 06732912T DK 1885380 T3 DK1885380 T3 DK 1885380T3
Authority
DK
Denmark
Prior art keywords
treatment
neoplastic diseases
metastatic neoplastic
sodium metaarsenite
metaarsenite
Prior art date
Application number
DK06732912.8T
Other languages
English (en)
Inventor
Sang-Bong Lee
Yong-Jin Yang
Original Assignee
Kominox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox Inc filed Critical Kominox Inc
Application granted granted Critical
Publication of DK1885380T3 publication Critical patent/DK1885380T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
DK06732912.8T 2005-05-09 2006-05-09 Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme DK1885380T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05076071A EP1721615A1 (en) 2005-05-09 2005-05-09 Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
PCT/KR2006/001731 WO2006121280A1 (en) 2005-05-09 2006-05-09 Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis

Publications (1)

Publication Number Publication Date
DK1885380T3 true DK1885380T3 (da) 2012-10-22

Family

ID=35197739

Family Applications (2)

Application Number Title Priority Date Filing Date
DK16162414T DK3067068T3 (da) 2005-05-09 2006-05-09 Natrium-meta-arsenit til anvendelse i behandlingen af myelomatose
DK06732912.8T DK1885380T3 (da) 2005-05-09 2006-05-09 Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK16162414T DK3067068T3 (da) 2005-05-09 2006-05-09 Natrium-meta-arsenit til anvendelse i behandlingen af myelomatose

Country Status (24)

Country Link
US (2) US20090011047A1 (da)
EP (5) EP1721615A1 (da)
JP (1) JP5026408B2 (da)
KR (3) KR20150085122A (da)
CN (2) CN101277707A (da)
AR (1) AR054448A1 (da)
AU (1) AU2006244767B2 (da)
BR (1) BRPI0608716A2 (da)
CA (3) CA2926846C (da)
CY (2) CY1113475T1 (da)
DK (2) DK3067068T3 (da)
ES (2) ES2754372T3 (da)
HK (1) HK1109736A1 (da)
HU (1) HUE046029T2 (da)
IL (3) IL187220A (da)
LT (1) LT3067068T (da)
PL (2) PL1885380T3 (da)
PT (1) PT1885380E (da)
RU (1) RU2401662C2 (da)
SG (5) SG10202100785PA (da)
SI (2) SI3067068T1 (da)
TW (5) TWI386214B (da)
WO (1) WO2006121280A1 (da)
ZA (1) ZA200710559B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20120045520A1 (en) * 2008-08-21 2012-02-23 Sang Bong Lee Pharmaceutical composition comprising arsenite for the treatment of malignancy
KR20120061908A (ko) * 2009-09-10 2012-06-13 코미녹스 인코포레이티드 암 줄기세포-표적 및 약물 내성 암 치료
AU2010295841A1 (en) * 2009-09-18 2012-03-29 Kominox, Inc. Methods for treating brain tumors
EP2524226A1 (en) * 2010-01-13 2012-11-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Promyelocytic leukemia protein as a redox sensor
US8993587B2 (en) * 2011-01-11 2015-03-31 Universitat Basel Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression
WO2012131487A2 (en) * 2011-03-30 2012-10-04 Kominox, Inc. Compositions and methods for the treatment of cancer
KR101309844B1 (ko) * 2013-03-15 2013-09-23 박상채 항암 활성 증진용 한약재 및 이의 제조방법
RU2618405C1 (ru) * 2015-12-31 2017-05-03 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ определения продолжительности адъювантной химиотерапии при местно-распространенном колоректальном раке с метастазами в регионарные лимфоузлы после радикальных оперативных вмешательств
US10806768B2 (en) * 2016-05-26 2020-10-20 Stephen N. Pitcher Composition for promoting metallothionein production
JP7080230B2 (ja) 2016-12-01 2022-06-03 ユーファーマ・プロプライアタリー・リミテッド 砒素組成物
KR20210016513A (ko) * 2018-03-22 2021-02-16 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 메타 아비산염을 포함하는 약학 조성물 및 제조 방법
WO2019234112A1 (en) * 2018-06-05 2019-12-12 Katholieke Universiteit Leuven Combination treatment of arsenic oxide and antiandrogens
JOP20220192A1 (ar) * 2020-02-16 2023-01-30 Panaphix Inc طريقة علاج باستخدام ميتا-الزرنيخ
KR20220020637A (ko) * 2020-08-12 2022-02-21 이상봉 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물
KR20220020633A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 주사제 조성물
KR20220020635A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 외용제 조성물
CN112336746A (zh) * 2020-10-23 2021-02-09 内蒙古科技大学包头医学院 一种膀胱癌灌注化疗药物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
FR2431686A1 (fr) 1978-07-20 1980-02-15 Nestle Sa Soc Ass Tech Prod Mecanisme de dosage et d'equilibrage et machine de remplissage comprenant un tel mecanisme
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
KR930001917A (ko) * 1991-07-26 1993-02-22 김두석 악성 종양 치료제의 제조방법
CA2183547C (en) 1994-02-18 2002-05-14 Tamara Vasilievna Vorobieva Compositions for treating defective cell functions
CA2307208A1 (en) * 1997-10-15 1999-04-22 Polarx Biopharmaceuticals, Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
BR9814857A (pt) 1997-11-10 2001-12-26 Sloan Kettering Inst Cancer Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
TW200408407A (en) 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
BR0215689A (pt) * 2002-04-10 2005-02-01 Korea Microbiological Lab Ltd Composição farmacêutica compreendendo arsênico para o tratamento de malignidade
KR100632250B1 (ko) * 2004-02-16 2006-10-11 정태호 비소 화합물을 유효성분으로 하는 항암제
US20060104292A1 (en) 2004-11-15 2006-05-18 Gupta Vivek G System and methods for supporting multiple communications interfaces with single client interface
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
KR20120061908A (ko) 2009-09-10 2012-06-13 코미녹스 인코포레이티드 암 줄기세포-표적 및 약물 내성 암 치료

Also Published As

Publication number Publication date
SI1885380T1 (sl) 2013-01-31
LT3067068T (lt) 2019-12-10
JP5026408B2 (ja) 2012-09-12
KR20080030559A (ko) 2008-04-04
JP2008546640A (ja) 2008-12-25
AU2006244767A1 (en) 2006-11-16
ZA200710559B (en) 2008-10-29
CA2840609C (en) 2016-08-16
SG10201602555WA (en) 2016-05-30
SG175633A1 (en) 2011-11-28
SG10202100785PA (en) 2021-02-25
TW201615200A (zh) 2016-05-01
WO2006121280A1 (en) 2006-11-16
IL187220A (en) 2014-11-30
CA2608035C (en) 2015-02-17
TWI539957B (zh) 2016-07-01
TW201540306A (zh) 2015-11-01
CA2608035A1 (en) 2006-11-16
TWI522105B (zh) 2016-02-21
HK1109736A1 (en) 2008-06-20
IL229975A0 (en) 2014-01-30
KR20150085122A (ko) 2015-07-22
BRPI0608716A2 (pt) 2010-12-07
RU2401662C2 (ru) 2010-10-20
HUE046029T2 (hu) 2020-01-28
TW201302208A (zh) 2013-01-16
KR101413731B1 (ko) 2014-07-10
PL1885380T3 (pl) 2013-02-28
IL187220A0 (en) 2008-02-09
PT1885380E (pt) 2012-10-11
SG10201405278SA (en) 2015-05-28
US20160199411A1 (en) 2016-07-14
RU2007145489A (ru) 2009-06-20
US20090011047A1 (en) 2009-01-08
EP1885380B1 (en) 2012-07-11
CA2926846C (en) 2019-04-02
SI3067068T1 (sl) 2020-02-28
PL3067068T3 (pl) 2020-08-10
TW201500046A (zh) 2015-01-01
CY1122522T1 (el) 2021-01-27
ES2394264T3 (es) 2013-01-30
CN104758312A (zh) 2015-07-08
CA2840609A1 (en) 2006-11-16
TWI574692B (zh) 2017-03-21
EP1885380A1 (en) 2008-02-13
IL229975A (en) 2017-12-31
IL244728A0 (en) 2016-04-21
CY1113475T1 (el) 2016-06-22
EP3067068A1 (en) 2016-09-14
SG177983A1 (en) 2012-02-28
EP1885380A4 (en) 2009-02-18
AU2006244767B2 (en) 2011-06-16
TWI386214B (zh) 2013-02-21
TW200716144A (en) 2007-05-01
KR20160035101A (ko) 2016-03-30
CN101277707A (zh) 2008-10-01
US11464859B2 (en) 2022-10-11
EP2762145A1 (en) 2014-08-06
EP3067068B1 (en) 2019-08-14
EP1721615A1 (en) 2006-11-15
DK3067068T3 (da) 2019-11-18
ES2754372T3 (es) 2020-04-17
CA2926846A1 (en) 2006-11-16
EP2361628A1 (en) 2011-08-31
AR054448A1 (es) 2007-06-27

Similar Documents

Publication Publication Date Title
DK1885380T3 (da) Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme
ATE380780T1 (de) Wasserbehandlungskartuschenabsperrung
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
ATE525088T1 (de) Kombinationstherapie
CY2200156T2 (el) Επεξεργασια λυματων
DE602005005527D1 (de) Verschlussdüse
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2204146T4 (da) Fodtøjsortose
DE602005019525D1 (de) Verschlussdüse
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1814555T3 (da) S-mirtazapin til behandling af hedeture
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK2107906T3 (da) Hidtil ukendt terapeutisk anvendelse til behandling af leukæmier
BRPI0719997A2 (pt) Uso de epotilonas no tratamento de osteoporose e doenças relacionadas
NO20054279D0 (no) Knivsliper
DK2001499T3 (da) Anvendelse af TGS-6 til behandling af osteoporose
DK1773451T3 (da) Anvendelse af 7-t-butoxyiminomethylcamptothecin til behandling af uterine neoplasmer
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini
FI6726U1 (fi) Hieromalaite
ATA13282004A (de) Massagegerät
IS8496A (is) Samsetningar til meðhöndlunar á fjölgunarsjúkdómum